The estimated Net Worth of Cynthia L Feldmann is at least $1.44 Million dollars as of 15 May 2024. Ms. Feldmann owns over 2,000 units of Steris Plc stock worth over $654,772 and over the last 9 years she sold STE stock worth over $498,890. In addition, she makes $289,882 as Independent Director at Steris Plc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Feldmann STE stock SEC Form 4 insiders trading
Cynthia has made over 11 trades of the Steris Plc stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 2,000 units of STE stock worth $172,460 on 15 May 2024.
The largest trade she's ever made was selling 4,744 units of Steris Plc stock on 3 November 2016 worth over $308,265. On average, Cynthia trades about 724 units every 71 days since 2015. As of 15 May 2024 she still owns at least 2,705 units of Steris Plc stock.
You can see the complete history of Ms. Feldmann stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Cynthia Feldmann biography
Cynthia L. Feldmann CPA serves as Independent Director of the Company. She is director since March 2005 and President and Founder of Jetty Lane Associates, a consulting firm, from December 2005 to December 2011. Ms. Feldmann is a retired certified public accountant with 27 years of experience in two large global accounting firms. From 2003 to 2005, Ms. Feldmann served as the Life Sciences Business Development Officer for the Boston law firm Palmer & Dodge, LLP. From 1994 to 2002, Ms. Feldmann was a partner with KPMG LLP, primarily serving as Partner-in-Charge of its National Medical Technologies Practice. From 1975 to 1994, Ms. Feldmann was employed by Coopers & Lybrand (now PricewaterhouseCoopers LLP), and during that time was named Partner-in-Charge of its Life Sciences practice. Ms. Feldmann has a Bachelor of Science, Accounting, and holds a Master Professional Director Certification from the American College of Corporate Directors. Ms. Feldmann served as a director of HeartWare International, Inc. until August 2016 and served as a director of Hanger, Inc. until January 2018. Ms. Feldmann is a director and chairs the audit committee of UFP Technologies, Inc.
What is the salary of Cynthia Feldmann?
As the Independent Director of Steris Plc, the total compensation of Cynthia Feldmann at Steris Plc is $289,882. There are 17 executives at Steris Plc getting paid more, with Walter Rosebrough having the highest compensation of $6,458,640.
How old is Cynthia Feldmann?
Cynthia Feldmann is 67, she's been the Independent Director of Steris Plc since 2005. There are 3 older and 18 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.
What's Cynthia Feldmann's mailing address?
Cynthia's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Insiders trading at Steris Plc
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough, and John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
What does Steris Plc do?
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
What does Steris Plc's logo look like?
Complete history of Ms. Feldmann stock trades at UFP Technologies, Alexandria Real Estate Equities, Steris Plc, and Frequency Therapeutics Inc
Steris Plc executives and stock owners
Steris Plc executives and other stock owners filed with the SEC include:
-
Walter Rosebrough,
President, Chief Executive Officer, Director -
Walter M. Rosebrough Jr.,
CEO Emeritus & Sr. Advisor -
Michael Tokich,
Chief Financial Officer, Senior Vice President -
Daniel Carestio,
Chief Operating Officer, Senior Vice President -
J. Adam Zangerle,
Senior Vice President, General Counsel, Secretary -
Daniel A. Carestio,
Pres, CEO & Director -
Cary Majors,
Vice President - North America Commercial Operations -
Michael J. Tokich,
Sr. VP & CFO -
John Adam Zangerle,
Sr. VP, Gen. Counsel, Sec. -
Cary L. Majors,
Sr. VP of North America Commercial Operations -
Mohsen Sohi,
Independent Chairman of the Board -
David Lewis,
Independent Director -
Jacqueline Kosecoff,
Independent Director -
Richard Steeves,
Independent Director -
Richard Breeden,
Independent Director -
Loyal Wilson,
Independent Director -
Nirav Shah,
Independent Director -
Cynthia Feldmann,
Independent Director -
Duncan Nichol,
Independent Director -
Michael Wood,
Independent Director -
Christopher Holland,
Director -
Renato Tamaro,
Vice President and Corporate Treasurer -
Renato G. Tamaro,
VP & Corp. Treasurer -
Julia K. Madsen,
Sr. VP of Life Sciences -
Mary Clare Fraser,
VP & Chief HR Officer -
Julie Winter,
VP of Investor Relations & Corp. Communications -
Karen L. Burton,
Chief Accounting Officer, VP & Controller -
Esther M. Alegria,
Director -
Kathleen Bardwell,
Sr.V. P. & C.C.O. -
Sudhir K Pahwa,
Sr. V.P., IPT -
Suzanne V Forsythe,
V. P. - Human Resources -
Gulam Amjad Khan,
Sr. V.P., Procedural Solutions -
Adrian Vincent Coward,
Sr. V. P., Healthcare Services -
John P Wareham,
Director -
Michiel De Zwaan,
V.P., Human Resources & CHRO -
Kevin M Mcmullen,
Director -
Mary Clare Fraser,
SVP & Chief HRO -
Julia Madsen,
Senior VP, Life Sciences -
Paul Edward Martin,
Director -
Andrew Xilas,
SVP and GM, Dental -
Kenneth E Kohler,
SVP & GM, AST -
Karen L Burton,
VP & CAO